Tchaikapharma High Quality Medicines AD reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was BGN 42.43 million compared to BGN 40.11 million a year ago. Revenue was BGN 42.53 million compared to BGN 40.39 million a year ago. Net income was BGN 1.67 million compared to BGN 0.428 million a year ago. Basic earnings per share from continuing operations was BGN 0.02 compared to BGN 0.007 a year ago.